Podcast

How Drug Hunter Grew to $2M ARR

In this episode, Alexej discusses with Dennis his shift from biotech to founding Drug Hunter, a drug discovery subscription service.

Interviewee Introduction: Dennis Hu

This episode features an interview with Dennis, a chemist-turned-founder who launched Drug Hunter, a B2B subscription service for drug discovery professionals. Dennis discusses his academic background, including a fast-tracked PhD from Stanford and work in the biotech industry, before founding Drug Hunter. He shares insights on the initial challenges, such as pricing strategies and deciding on product features, and how the company has grown to serve over 150 institutions with an ARR exceeding 2 million dollars. Key takeaways include the importance of focusing on what customers willing to pay the most demand, and how pivoting from offering consultancy to prioritizing a subscription model was crucial for growth. Additionally, Dennis touches on his journey navigating product development and hiring, along with the impact of organic growth and potential future directions for Drug Hunter.

Important Links:

Grow with NUOPTIMA.

Book a call with our growth team to see what an Organic plus AI Search strategy looks like for your business.

90-day milestone guarantee · One MSP per niche & region · Done-for-you